Current Drug Metabolism

Editor-in-Chief:

Michael Sinz

Bristol Myers Squibb

Princeton, NJ

USA

 

Back

Become EABM
Become Reviewer

Prediction of Maximum Exposure in Poor Metabolizers Following Inhibition of Nonpolymorphic Pathways

Volume:7   Issue:3
Pp: 295-299
C. Collins, R. Levy, I. Ragueneau-Majlessi and H. Hachad
DOI: 10.2174/138920006776359301

Involvement of Cytoskeleton in AhR-Dependent CYP1A1 Expression

Volume:7   Issue:3
Pp: 301-313
Zdenek Dvorak, Radim Vrzal, Jitka Ulrichova, Jean-Marc Pascussi, Patrick Maurel and Martin Modriansky
DOI: 10.2174/138920006776359310

A Critical Evaluation of the Experimental Design of Studies of Mechanism Based Enzyme Inhibition, with Implications for In Vitro-In Vivo Extrapolation

Volume:7   Issue:3
Pp: 315-334
F. Ghanbari, K. Rowland-Yeo, J. C. Bloomer, S. E. Clarke, M. S. Lennard, G. T. Tucker and A. Rostami-Hodjegan
DOI: 10.2174/138920006776359293